Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States

Tara Alpert,Erica Lasek‐Nesselquist, Brito Af, Valesano Al,Jessica E. Rothman, MacKay Mj, Petrone Me, Breban Mi, Watkins Ae, Vogels Cb,Alexis Russell, Kelly Jp,Matthew Shudt,Jonathan Plitnick,Erasmus Schneider, Fitzsimmons Wj,Gaurav Khullar,Jessica Metti, Dudley Jt,Megan Nash,J Wang,Liu C,Pei Hui,Anthony Muyombwe,Randy Downing,Jafar Razeq, Bart Sm,Steven Murphy,Caleb Neal,Eva Laszlo, Landry Ml, Cook Pw, Fauver, Mason Ce,Adam S. Lauring,St. George K, MacCannell Dr, Grubaugh Nd

medRxiv (Cold Spring Harbor Laboratory)(2021)

Cited 0|Views8
No score
Abstract
Summary The emergence and spread of SARS-CoV-2 lineage B.1.1.7, first detected in the United Kingdom, has become a global public health concern because of its increased transmissibility. Over 2500 COVID-19 cases associated with this variant have been detected in the US since December 2020, but the extent of establishment is relatively unknown. Using travel, genomic, and diagnostic data, we highlight the primary ports of entry for B.1.1.7 in the US and locations of possible underreporting of B.1.1.7 cases. Furthermore, we found evidence for many independent B.1.1.7 establishments starting in early December 2020, followed by interstate spread by the end of the month. Finally, we project that B.1.1.7 will be the dominant lineage in many states by mid to late March. Thus, genomic surveillance for B.1.1.7 and other variants urgently needs to be enhanced to better inform the public health response.
More
Translated text
Key words
sars-cov
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined